z-logo
open-access-imgOpen Access

Impact of antiviral therapy with nucleos(t)ide analog on survival of patients with HBV-related small hepatocellular carcinomas

Author(s) -
Wei Yue,
Yongxiang Yi,
Tao Chen,
Wei Ye,
Wei Zhao
Publication year - 2019
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s201744
Subject(s) - medicine , hepatocellular carcinoma , adefovir , gastroenterology , hazard ratio , hepatitis b virus , hepatitis b , lamivudine , virus , virology , confidence interval
Hepatocellular carcinoma (HCC) is the second leading causes of cancer-related death. HCC is usually based on chronic liver disease, mainly including chronic hepatitis C virus infection or chronic hepatitis B virus (HBV) infection.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here